Nantong Jinghua Pharmaceutical Co.,Ltd.

About Nantong Jinghua Pharmaceutical Co.,Ltd.

Nantong Jinghua Pharmaceutical Co Ltd is a comprehensive, advanced and innovative GMP company, we focus on manufacture, R&D and sales of APIs, pharmaceutical intermediates. Our company produce Phenobarbital, Primidone, Fluorouracil, Phenylbutazone, Flucytosine, Piroxicam, and Propylthiouracil etc., in which the fist five products have CEP certificates.

  • CN
  • 2015
    On CPHI since
  • 4
  • 250 - 499
Company types
Pharmaceutical company
Primary activities
Pharmaceutical Company (generic finished products)
Contact info
  • No.20, 3 Haibin Road, Yanhai, Yanhai Economic Development Zone, Rudong, 226407, Nantong, Jiangsu, China
Meet us at

CPHI & PMEC China 2024

Shanghai New International Expo Center
19 - 21 June 2024

CPHI Milan 2024

Fiera Milano, Italy
08 Oct 2024 - 10 Oct 2024

Products from Nantong Jinghua Pharmaceutical Co.,Ltd. (5)

  • Phenobarbital

    Product Phenobarbital

    There are CEP and US DMF for this product, our main markets are regulatory market, such South America and European.
  • 1,4-Dioxane

    Product 1,4-Dioxane

    dioxane is mainly used in Pharmaceutical, cosmetic, spice and other chemical manufacturing area, are for solvent, reaction medium and extractant
  • Fluorouracil

    Product Fluorouracil

    There are CEP certificate and US DMF, approved by TGA, FDA and COFERPIS.
  • Phenylbutazone

    Product Phenylbutazone

    There are CEP certificate and US VMF, approved by FDA for more than three years. Our main markets are European and US.
  • Primidone

    Product Primidone

    There are CEP certificate and US DMF, approved by FDA, TGA and COFEPRIS.